insights_auto
Why is TWST down 6.78%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$155.65
arrow_downward
-6.78%(-11.32) 1D
$155.50
arrow_downward
-0.10% (-0.15)bedtimeAfter hours
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$158.26
High
$167.44
Low
$152.50
Mkt. cap
10.31B
Avg. vol.
2.33M
Volume
0.00
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$158.26
High
$167.44
Low
$152.50
Mkt. cap
10.31B
Avg. vol.
2.33M
Volume
0.00
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
AD HOC NEWS
·
3 hours ago
Twist Bioscience stock fell 6.78 percent while its CEO sold shares
Stock Titan
·
9 hours ago
Under a trading plan, Twist Bioscience (TWST) CEO sells 4,548 shares on October 5, 2026.
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp